Drug Trial Radar · NCT05356195
Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Transfusion-Dependent β-Thalassemia (TDT)
Last checked: Nov 19, 2026Latest source record: Jul 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
16
Actual
Start
May 3, 2022
Primary completion
Nov 14, 2027
Study completion Nov 14, 2027
Sponsor
- Lead sponsor
- Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals (VRTX)
- Sponsor type
- Industry
- Collaborators
- CRISPR Therapeutics
- First posted
- May 2, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 2 years, up to 11 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a single-dose, open-label study in pediatric participants with TDT. The study will evaluate the safety and efficacy of autologous CRISPR-Cas9 modified CD34+ human hematopoietic stem and progenitor cells (hHSPCs) (CTX001).
Conditions
- Beta-Thalassemia
- Thalassemia
- Genetic Diseases, Inborn
- Hematologic Diseases
- Hemoglobinopathies
Interventions
CTX001Biological
Administered by intravenous infusion following myeloablative conditioning with busulfan.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of Participants who Achieve Transfusion Independence for at Least 12 Consecutive Months (TI12)Time frame: Up to 24 Months After CTX001 Infusion
Locations
6 sites in 5 countries. Site status is shown where the registry gives one.
TriStar Medical Group Children's Specialists - Pediatric Oncology
Nashville, Tennessee
Hospital for Sick Children - Hematology
Toronto, Canada
University Hospital Dusseldorf - Department of Pediatric Oncology, Hematology and Clinical Immunology
Düsseldorf, Germany
IRCSS Ospedale Pediatrico Bambino Gesu - Dipartimento di Onco-Ematologia e Terapia Cellulare e Genica
Rome, Italy
Great Ormond Street Hospital for Children
London, United Kingdom
St.Mary's Hospital - Children's Clinical Research Facility
London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.